Logo image of ESON.LS

ESTORIL SOL SGPS SA-REG SHS (ESON.LS) Stock Fundamental Analysis

ELI:ESON - Euronext Lisbon - PTESO0AM0000 - Common Stock - Currency: EUR

4.6  0 (0%)

Fundamental Rating

2

Overall ESON gets a fundamental rating of 2 out of 10. We evaluated ESON against 0 industry peers in the Unkown industry. While ESON seems to be doing ok healthwise, there are quite some concerns on its profitability. ESON does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ESON has reported negative net income.
ESON had a positive operating cash flow in the past year.
Of the past 5 years ESON 4 years were profitable.
ESON had a positive operating cash flow in 4 of the past 5 years.
ESON.LS Yearly Net Income VS EBIT VS OCF VS FCFESON.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

1.2 Ratios

The last Return On Invested Capital (3.34%) for ESON is well below the 3 year average (13.45%), which needs to be investigated, but indicates that ESON had better years and this may not be a problem.
Industry RankSector Rank
ROA -2.48%
ROE -6.68%
ROIC 3.34%
ROA(3y)9.62%
ROA(5y)3.75%
ROE(3y)14.71%
ROE(5y)5.57%
ROIC(3y)13.45%
ROIC(5y)N/A
ESON.LS Yearly ROA, ROE, ROICESON.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20

1.3 Margins

In the last couple of years the Profit Margin of ESON has declined.
In the last couple of years the Operating Margin of ESON has grown nicely.
In the last couple of years the Gross Margin of ESON has remained more or less at the same level.
Industry RankSector Rank
OM 10.01%
PM (TTM) N/A
GM 98.16%
OM growth 3YN/A
OM growth 5Y1.99%
PM growth 3YN/A
PM growth 5Y-18.34%
GM growth 3Y-0.1%
GM growth 5Y0.24%
ESON.LS Yearly Profit, Operating, Gross MarginsESON.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80

4

2. Health

2.1 Basic Checks

ESON has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ESON remains at a similar level compared to 1 year ago.
The number of shares outstanding for ESON remains at a similar level compared to 5 years ago.
Compared to 1 year ago, ESON has an improved debt to assets ratio.
ESON.LS Yearly Shares OutstandingESON.LS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ESON.LS Yearly Total Debt VS Total AssetsESON.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 1.01, we must say that ESON is in the distress zone and has some risk of bankruptcy.
ESON has a debt to FCF ratio of 0.29. This is a very positive value and a sign of high solvency as it would only need 0.29 years to pay back of all of its debts.
ESON has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Although ESON does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.29
Altman-Z 1.01
ROIC/WACC0.37
WACC9.04%
ESON.LS Yearly LT Debt VS Equity VS FCFESON.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

ESON has a Current Ratio of 1.62. This is a normal value and indicates that ESON is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.43 indicates that ESON should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.43
ESON.LS Yearly Current Assets VS Current LiabilitesESON.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

ESON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -135.34%.
Measured over the past years, ESON shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.29% on average per year.
Looking at the last year, ESON shows a very negative growth in Revenue. The Revenue has decreased by -14.21% in the last year.
Measured over the past years, ESON shows a small growth in Revenue. The Revenue has been growing by 2.52% on average per year.
EPS 1Y (TTM)-135.34%
EPS 3YN/A
EPS 5Y-16.29%
EPS Q2Q%-194.48%
Revenue 1Y (TTM)-14.21%
Revenue growth 3Y17.83%
Revenue growth 5Y2.52%
Sales Q2Q%-12.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ESON.LS Yearly Revenue VS EstimatesESON.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ESON. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ESON.LS Price Earnings VS Forward Price EarningsESON.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 31.25
EV/EBITDA N/A
ESON.LS Per share dataESON.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.64%, ESON has a reasonable but not impressive dividend return.
Compared to an average S&P500 Dividend Yield of 2.43, ESON pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.64%

5.2 History

On average, the dividend of ESON grows each year by 18.43%, which is quite nice.
Dividend Growth(5Y)18.43%
Div Incr Years0
Div Non Decr Years0
ESON.LS Yearly Dividends per shareESON.LS Yearly Dividends per shareYearly Dividends per share 2019 2024 0.1 0.2 0.3 0.4

5.3 Sustainability

ESON has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-145.2%
EPS Next 2YN/A
EPS Next 3YN/A
ESON.LS Yearly Income VS Free CF VS DividendESON.LS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

ESTORIL SOL SGPS SA-REG SHS

ELI:ESON (4/30/2025, 7:00:00 PM)

4.6

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap55.15M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.64%
Yearly Dividend1.3
Dividend Growth(5Y)18.43%
DP-145.2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF 31.25
P/OCF 2.16
P/B 0.47
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.15
FCFY3.2%
OCF(TTM)2.13
OCFY46.24%
SpS9.49
BVpS9.88
TBVpS-5.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.48%
ROE -6.68%
ROCE 4.23%
ROIC 3.34%
ROICexc 4.49%
ROICexgc 50.66%
OM 10.01%
PM (TTM) N/A
GM 98.16%
FCFM 1.55%
ROA(3y)9.62%
ROA(5y)3.75%
ROE(3y)14.71%
ROE(5y)5.57%
ROIC(3y)13.45%
ROIC(5y)N/A
ROICexc(3y)48.44%
ROICexc(5y)N/A
ROICexgc(3y)112.04%
ROICexgc(5y)N/A
ROCE(3y)17.45%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y29.92%
ROICexc growth 3YN/A
ROICexc growth 5Y-19.41%
OM growth 3YN/A
OM growth 5Y1.99%
PM growth 3YN/A
PM growth 5Y-18.34%
GM growth 3Y-0.1%
GM growth 5Y0.24%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.29
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 20.85%
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.43
Altman-Z 1.01
F-Score4
WACC9.04%
ROIC/WACC0.37
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)12.27%
Cap/Sales(5y)7.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-135.34%
EPS 3YN/A
EPS 5Y-16.29%
EPS Q2Q%-194.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.21%
Revenue growth 3Y17.83%
Revenue growth 5Y2.52%
Sales Q2Q%-12.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-64.59%
EBIT growth 3YN/A
EBIT growth 5Y4.56%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-95.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.71%
OCF growth 3YN/A
OCF growth 5Y-2.54%